The data show that the combination of GM-CSF and Cy with the vaccine was most effective in arresting glioma growth progression as published in Chapter 7 of the thesis of A. Stathopoulos, Vaccine antigen preparation used to evaluate therapeutic immunization when combined with GM-CSF [25]. Here, CSF2 is linked to central nervous system cancer.